ProQuest Associates III LLC

10% owner at NOVADEL PHARMA INC · on record since Apr 14, 2006
10% owner at CADENCE PHARMACEUTICALS INC · on record since Oct 31, 2006
10% owner at AGILE THERAPEUTICS INC · on record since May 22, 2014

Insider trading activity of ProQuest Associates III LLC

Transactions on record: 5; since Jan 26, 2007

Open-market buys: 2; $5.9M

Open-market sells: 0

Companies traded: 2; last filing Jan 23, 2015

Figures computed from official regulatory filings — .

Companies where ProQuest Associates III LLC has traded

AGILE THERAPEUTICS INC1 tx · $4.8M · Jan 23, 2015
NOVADEL PHARMA INC4 tx · $1.1M · Jun 25, 2008

Track record of ProQuest Associates III LLC

Open-market buys: 5

Last buy: Jan 23, 2015

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of ProQuest Associates III LLC

Co-insiders of ProQuest Associates III LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
AGILE THERAPEUTICS INCListing unverified	Jan 23, 2015	Buy	811,966	5.85 USD	$4.8M	conv 44First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jun 25, 2008	BuyD (derivative)	5,000,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jun 25, 2008	BuyD (derivative)	3,000,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jan 26, 2007	Buy	763,449	1.45	$1.1M	conv 32First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jan 26, 2007	BuyD (derivative)	1,751,854	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
AGILE THERAPEUTICS INCListing unverified	Jan 23, 2015	Buy	811,966	5.85 USD	$4.8M	conv 44First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jun 25, 2008	BuyD (derivative)	5,000,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jun 25, 2008	BuyD (derivative)	3,000,000	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jan 26, 2007	Buy	763,449	1.45	$1.1M	conv 32First in 12mo	SEC
NOVADEL PHARMA INCListing unverified	Jan 26, 2007	BuyD (derivative)	1,751,854	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	First in 12mo	SEC